Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Inovio Pharma sell geldnutzer

Inovio Pharma
Start price
€1.88
20.09.22 / 50%
Target price
€1.60
20.09.23
Performance (%)
-7.46%
End price
€1.74
03.10.22
Summary
This prediction ended on 03.10.22 with a price of €1.74. With a performance of -7.46%, the SELL prediction by geldnutzer was trending in the right direction. geldnutzer has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Inovio Pharma - - -
iShares Core DAX® -2.196% -0.532% 12.492%
iShares Nasdaq 100 -0.074% 1.843% 40.598%
iShares Nikkei 225® -2.154% -1.109% 22.295%
iShares S&P 500 -0.501% 1.475% 28.278%

According to geldnutzer what are the pros and cons of Inovio Pharma for the foreseeable future?

Pros
Future proof or reliable business model
Cons
Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Probably not worthwhile Investment
Few uniques
Little Investments for future growth
High valuation
very negative Cash Flow expected
Significant cyclical dependencies
Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Little known brand
Below average Management
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Bad rating
Little innovation
Bad culture

Comments by geldnutzer for this prediction

In the thread Inovio Pharma diskutieren
Prediction Sell
Perf. (%) -7.46%
Target price 1.600
Change
Ends at 20.09.23

Sell mit Kursziel 1,6

geldnutzer 
0
Report Share
20.09.22
In the thread Trading Inovio Pharma
Prediction Buy
Perf. (%) -7.46%
Target price 1.600
Change
Ends at 20.09.23

Sell beendet

geldnutzer 
0
Report Share
03.10.22

Stopped prediction by geldnutzer for Inovio Pharma

sell
Inovio Pharma

Start price
Target price
Perf. (%)
€1.47
13.02.23
€0.30
13.02.24
-63.81%
14.02.24

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
geldnutzer 
13.02.23 50%
buy
Inovio Pharma

Start price
Target price
Perf. (%)
€1.74
03.10.22
€2.35
03.10.23
-15.49%
13.02.23

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
geldnutzer 
03.10.22 50%
buy
Inovio Pharma

Start price
Target price
Perf. (%)
€2.12
03.08.22
€2.60
03.08.23
-11.19%
20.09.22

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
geldnutzer 
03.08.22 50%
sell
Inovio Pharma

Start price
Target price
Perf. (%)
€3.05
12.04.22
€1.60
12.04.23
-30.60%
03.08.22

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
geldnutzer 
12.04.22 50%
buy
Inovio Pharma

Start price
Target price
Perf. (%)
€6.45
27.11.21
€3.30
27.11.22
-52.69%
12.04.22

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
geldnutzer 
27.11.21 50%
sell
Inovio Pharma

Start price
Target price
Perf. (%)
€6.92
10.07.21
€5.80
10.07.22
-6.86%
27.11.21

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
geldnutzer 
10.07.21 50%
buy
Inovio Pharma

Start price
Target price
Perf. (%)
€11.30
20.02.21
€6.80
20.02.22
-38.75%
10.07.21

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
geldnutzer 
20.02.21 50%
sell
Inovio Pharma

Start price
Target price
Perf. (%)
€9.35
10.12.20
€7.00
10.12.21
20.86%
20.02.21

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
geldnutzer 
10.12.20 50%
buy
Inovio Pharma

Start price
Target price
Perf. (%)
€10.60
29.11.20
€12.00
29.11.21
-11.79%
10.12.20

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
geldnutzer 
29.11.20 50%
sell
Inovio Pharma

Start price
Target price
Perf. (%)
€7.10
09.11.20
€5.00
09.11.21
49.30%
29.11.20

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
geldnutzer 
09.11.20 50%
buy
Inovio Pharma

Start price
Target price
Perf. (%)
€9.90
04.05.20
€12.00
04.11.21
-28.28%
09.11.20

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
geldnutzer 
04.05.20 50%
buy
Inovio Pharma

Start price
Target price
Perf. (%)
€4.44
25.01.20
€13.00
04.05.20
125.23%
04.05.20

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
geldnutzer 
25.01.20 50%
buy
Inovio Pharma

Start price
Target price
Perf. (%)
€7.98
24.05.17
€11.68
02.06.17
-13.45%
02.06.17

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
geldnutzer 
15.08.19 50%
buy
Inovio Pharma

Start price
Target price
Perf. (%)
€8.16
28.06.16
€10.64
09.08.16
-2.69%
09.08.16

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
geldnutzer 
15.08.19 50%
buy
Inovio Pharma

Start price
Target price
Perf. (%)
€5.88
27.02.16
€11.73
27.06.16
31.08%
27.06.16

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
geldnutzer 
15.08.19 50%
buy
Inovio Pharma

Start price
Target price
Perf. (%)
€5.30
10.02.16
€8.84
23.02.16
11.79%
23.02.16

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
geldnutzer 
15.08.19 50%